Cargando…

Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of In Vitro Screenings

Human cytomegalovirus (HCMV) is a ubiquitous betaherpesvirus that can cause severe disease following in utero exposure, during primary infection, or latent virus reactivation in immunocompromised populations. These complications lead to a 1- to 2-billion-dollar economic burden, making vaccine develo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Joseph W., Hancock, Trevor J., Dogra, Pranay, Patel, Ravi, Arav-Boger, Ravit, Williams, Angela D., Kennel, Stephen J., Wall, Jonathan S., Sparer, Tim E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374593/ https://www.ncbi.nlm.nih.gov/pubmed/30760613 http://dx.doi.org/10.1128/mSphere.00586-18

Ejemplares similares

Novel Heparan Sulfate-Binding Peptides for Blocking Herpesvirus Entry
por: Dogra, Pranay, et al.
Publicado: (2015)

The Use of Artificial Neural Networks in Prediction of Congenital CMV Outcome from Sequence Data
por: Arav-Boger, Ravit, et al.
Publicado: (2008)

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
por: He, Ran, et al.
Publicado: (2011)

An Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
por: He, Ran, et al.
Publicado: (2011)

Detection of a Single Identical Cytomegalovirus (CMV) Strain in Recently Seroconverted Young Women
por: Murthy, Suchetha, et al.
Publicado: (2011)

Prevalence, Magnitude, and Genotype Distribution of Urinary Cytomegalovirus (CMV) Shedding Among CMV-Seropositive Children and Adolescents in the United States
por: White, Jodie L, et al.
Publicado: (2019)

Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention
por: Pass, Robert F., et al.
Publicado: (2018)

Activation of Nucleotide Oligomerization Domain 2 (NOD2) by Human Cytomegalovirus Initiates Innate Immune Responses and Restricts Virus Replication
por: Kapoor, Arun, et al.
Publicado: (2014)

Human Cytomegalovirus Inhibits the PARsylation Activity of Tankyrase—A Potential Strategy for Suppression of the Wnt Pathway
por: Roy, Sujayita, et al.
Publicado: (2015)

Bacterial Muramyl Dipeptide (MDP) Restricts Human Cytomegalovirus Replication via an IFN-β-Dependent Pathway
por: Kapoor, Arun, et al.
Publicado: (2016)

Blood Viral Load (VL) Not Clinically Meaningful in Symptomatic Congenital Cytomegalovirus (cCMV) Infection
por: Marsico, Concetta, et al.
Publicado: (2017)

The Human Cytomegalovirus Chemokine vCXCL-1 Modulates Normal Dissemination Kinetics of Murine Cytomegalovirus In Vivo
por: Jackson, Joseph W., et al.
Publicado: (2019)

Antiviral Effects of Oleandrin
por: Newman, Robert A, et al.
Publicado: (2020)

MCMV Centrifugal Enhancement: A New Spin on an Old Topic
por: Hancock, Trevor J., et al.
Publicado: (2021)

2591. The Role of Neutralizing Antibodies (nAb) Against Cytomegalovirus (CMV) Epithelial Cell-entry in Patients with Self-limited (SL) CMV infection after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2019)

The Synthesis and Anti-Cytomegalovirus Activity of Piperidine-4-Carboxamides
por: Guo, Xin, et al.
Publicado: (2022)

Polymorphisms in Toll-like receptor genes influence antibody responses to cytomegalovirus glycoprotein B vaccine
por: Arav-Boger, Ravit, et al.
Publicado: (2012)

Genomic Markers Associated with Cytomegalovirus DNAemia in Kidney Transplant Recipients
por: Shapira, Guy, et al.
Publicado: (2023)

Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
por: Foster, James S., et al.
Publicado: (2023)

There Is Always Another Way! Cytomegalovirus’ Multifaceted Dissemination Schemes
por: Jackson, Joseph W., et al.
Publicado: (2018)

Artemisinin-Derived Dimers Have Greatly Improved Anti-Cytomegalovirus Activity Compared to Artemisinin Monomers
por: Arav-Boger, Ravit, et al.
Publicado: (2010)

Harnessing the Noncanonical Keap1-Nrf2 Pathway for Human Cytomegalovirus Control
por: Ghosh, Ayan K., et al.
Publicado: (2023)

Dual-Energy SPECT and the Development of Peptide p5+14 for Imaging Amyloidosis
por: Wall, Jonathan S., et al.
Publicado: (2017)

Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
por: Kwon, Ji-Soo, et al.
Publicado: (2017)

Latent Cytomegalovirus (CMV) Infection Does Not Detrimentally Alter T Cell Responses in the Healthy Old, But Increased Latent CMV Carriage Is Related to Expanded CMV-Specific T Cells
por: Jackson, Sarah E., et al.
Publicado: (2017)

Correlation of Cytomegalovirus (CMV) Disease Severity and Mortality With CMV Viral Burden in CMV-Seropositive Donor and CMV-Seronegative Solid Organ Transplant Recipients
por: McBride, Jacqueline M, et al.
Publicado: (2019)

LOCALIZATION OF THE TIBIAL ENTRY POINT
por: Labronici, Pedro José, et al.
Publicado: (2015)

The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV
por: Carbone, Javier
Publicado: (2016)

CMV Immunoglobulins for the Treatment of CMV Infections in Thoracic Transplant Recipients
por: Schulz, Uwe, et al.
Publicado: (2016)

Predictors of CMV Infection in CMV-Seropositive Kidney Transplant Recipients: Impact of Pretransplant CMV-Specific Humoral Immunity
por: Kirisri, Similan, et al.
Publicado: (2021)

Jain point laparoscopic entry in contraindications of Palmers point
por: Jain, Nutan, et al.
Publicado: (2022)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Common T-Cell-Receptor Motifs and Features in Patients with Cytomegalovirus (CMV)-Seronegative End-Stage Renal Disease Receiving a Peptide Vaccination against CMV
por: Bunse, Lukas, et al.
Publicado: (2022)

Stimulatory Effect of CMV Immunoglobulin on Innate Immunity and on the Immunogenicity of CMV Antigens
por: Deml, Ludwig, et al.
Publicado: (2021)

ASSESSMENT OF THE EFFECTIVENESS OF RAPID ANTIGEN TESTING AT POINTS OF ENTRY; PAKISTAN COVID-19 POINT OF ENTRY (POE) ANALYSIS
por: Nasir, Z., et al.
Publicado: (2023)

Comparison of Two Entry Methods for Laparoscopic Port Entry: Technical Point of View
por: Toro, Adriana, et al.
Publicado: (2012)

CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis
por: Goodman, A. L., et al.
Publicado: (2014)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

Amsterdam urban water system as entry point of river plastic pollution
por: Tasseron, Paolo, et al.
Publicado: (2023)

Limited Role for C. pneumoniae, CMV and HSV-1 in Cerebral Large and Small Vessel Atherosclerosis
por: Voorend, M, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_5ro7063iku8qhqtpjgc7ovsopn